title: [Assessment of survival and risk of hepatocellular carcinoma in patients with cirrhosis of mixed (viral, alcoholic) etiology].
abstract: OBJECTIVE
  To determine factors affecting overall survival and risk to develop hepatocellular carcinoma (HCC) in patients with hepatic cirrhosis (HC) of mixed (viral, alcoholic) etiology.
  
  
  METHODS
  Mono- and multi-variance analysis of prognostic effects of such factors as age of the patients, mixed infection VHB/VHC, markers of HBV replication, antibodies to nuclear antigen of HBV (HBcAb) without HBs-system in the serum ("isolated" HBcAb), duration of viral infection, alcohol intake and abuse, dilatation of the esophageal veins, some laboratory parameters were studied in 55 HC patients having at least one marker of hepatitis B virus (HBV) and/or hepatitis C virus (HCV), long history of alcohol abuse.
  
  
  RESULTS
  It was found that risk of HCC was associated with duration of alcohol abuse and infection, mixed HBV/HCV infection, age 60 and older. Of independent significance was only duration of alcohol abuse. Lethal outcomes in HC patients in the mixed infection were due to development of HCC (36%) and HC complications (64%). Survival of the patients was less in severe dilatation of the esophageal veins, high clinicolaboratory index, low level of serum albumin, presence of "isolated" BcAb and mixed viral infection.
  
  
  CONCLUSIONS
  Of the greatest prognostic efficacy in respect of survival was the model combining "isolated" HBcAb, the degree of esophageal veins dilatation and hepatitis activity.
authors.forename: T N
authors.initials: TN
authors.lastname: Lopatkina
authors.forename: E L
authors.initials: EL
authors.lastname: Tanashchuk
authors.forename: V E
authors.initials: VE
authors.lastname: Siutkin
authors.forename: I V
authors.initials: IV
authors.lastname: Popova
mesh_terms: D000437:Alcoholism / Q000150:complications*; D000956:Antigens, Viral / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000209:etiology* / Q000401:mortality; D005260:Female; D006509:Hepatitis B / Q000150:complications*; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D008103:Liver Cirrhosis / Q000209:etiology* / Q000401:mortality; D008113:Liver Neoplasms / Q000209:etiology* / Q000401:mortality; D008297:Male; D016133:Polymerase Chain Reaction; D012189:Retrospective Studies; D012306:Risk; D015996:Survival Rate
chemical_list: D000956:Antigens, Viral